Neurocrine Biosciences (NBIX) Research & Development: 2009-2018
Historic Research & Development for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2018 value amounting to $160.5 million.
- Neurocrine Biosciences' Research & Development rose 34.15% to $92.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $309.8 million, marking a year-over-year increase of 22.16%. This contributed to the annual value of $160.5 million for FY2018, which is 31.76% up from last year.
- Latest data reveals that Neurocrine Biosciences reported Research & Development of $160.5 million as of FY2018, which was up 31.76% from $121.8 million recorded in FY2017.
- In the past 5 years, Neurocrine Biosciences' Research & Development ranged from a high of $160.5 million in FY2018 and a low of $46.4 million during FY2014.
- Moreover, its 3-year median value for Research & Development was $121.8 million (2017), whereas its average is $125.5 million.
- Data for Neurocrine Biosciences' Research & Development shows a peak YoY surged of 75.53% (in 2015) over the last 5 years.
- Neurocrine Biosciences' Research & Development (Yearly) stood at $46.4 million in 2014, then spiked by 75.53% to $81.5 million in 2015, then grew by 15.71% to $94.3 million in 2016, then increased by 29.20% to $121.8 million in 2017, then surged by 31.76% to $160.5 million in 2018.